Properties
Description
Alflutinib is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells.
Molecular Formula
C28H31F3N8O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Alflutinib is utilized to investigate its inhibitory effects on EGFR-HER2, contributing to the development of targeted therapies for cancers driven by these receptors.